IL10 and campylobacteriosis: Most recently, the secondary abiotic IL10 deficient murine model of campylobacteriosis was standardized and could be developed to the preclinical level for pharmaceutical analysis of alternative drugs, including ascorbate and vitamin D, which effectively suppressed C. jejuni-induced inflammation in the course of campylobacteriosis [20,160].